HDAC inhibition prevents tumor growth (209), and the retrohydroxamate ligand has been utilized in small molecule HDAC inhibitors (210), suggesting that amamistatins may be useful in cancer therapy and warrant further investigation. The gene discussed is HDAC9; the disease is neoplasm.